Showing posts with label Therapeutic Market. Show all posts
Showing posts with label Therapeutic Market. Show all posts

Tuesday, 30 May 2017

United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry 2016 Market Research Report Trends and Forecast

ResearchMoz added Latest Research Report titled " United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry 2016 Market Research Report " to it's Large Report database.

The United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Commercializing Biomarkers in Therapeutic and Diagnostic Applications industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Commercializing Biomarkers in Therapeutic and Diagnostic Applications market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=714521

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Commercializing Biomarkers in Therapeutic and Diagnostic Applications industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 148 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Table of Content

1 Industry Overview
1.1 Definition and Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.1.1 Definition of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.1.2 Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.2 Classification of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.3 Applications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.4 Industry Chain Structure of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.5 Industry Overview of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.6 Industry Policy Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
1.7 Industry News Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications

2 Manufacturing Cost Structure Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.1 Bill of Materials (BOM) of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.2 BOM Price Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.3 Labor Cost Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.4 Depreciation Cost Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.5 Manufacturing Cost Structure Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.6 Manufacturing Process Analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
2.7 United States Price, Cost and Gross of Commercializing Biomarkers in Therapeutic and Diagnostic Applications 2011-2016

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Monday, 14 November 2016

Familial Adenomatous Polyposis Coli Therapeutic Market Research Report Analysis- Pipeline Review, H1 2014

ResearchMoz added Latest Research Report titled " Familial Adenomatous Polyposis Coli - Pipeline Review, H1 2014 " to it's Large Report database.

Familial Adenomatous Polyposis Coli - Pipeline Review, H1 2014

Summary

Global Markets Directs, Familial Adenomatous Polyposis Coli - Pipeline Review, H1 2014, provides an overview of the Familial Adenomatous Polyposis Colis therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Familial Adenomatous Polyposis Coli, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Familial Adenomatous Polyposis Coli and special features on late-stage and discontinued projects.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=195126

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Familial Adenomatous Polyposis Coli Overview 6
Therapeutics Development 7
Pipeline Products for Familial Adenomatous Polyposis Coli - Overview 7
Pipeline Products for Familial Adenomatous Polyposis Coli - Comparative Analysis 8
Familial Adenomatous Polyposis Coli - Therapeutics under Development by Companies 9
Familial Adenomatous Polyposis Coli - Therapeutics under Investigation by Universities/Institutes 10
Familial Adenomatous Polyposis Coli - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Familial Adenomatous Polyposis Coli - Products under Development by Companies 14
Familial Adenomatous Polyposis Coli - Products under Investigation by Universities/Institutes 15
Familial Adenomatous Polyposis Coli - Companies Involved in Therapeutics Development 16
Marina Biotech, Inc. 16
S.L.A. Pharma AG 17
Cancer Prevention Pharmaceuticals, Inc. 18
Familial Adenomatous Polyposis Coli - Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Combination Products 20
Assessment by Target 21
Assessment by Mechanism of Action 23
Assessment by Route of Administration 25

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Age Related Macular Degeneration therapeutic Market Research Report Analysis - Pipeline Review, H1 2014

ResearchMoz added Latest Research Report titled " Age Related Macular Degeneration - Pipeline Review, H1 2014 " to it's Large Report database.

Age Related Macular Degeneration - Pipeline Review, H1 2014

Summary

Global Markets Directs, Age Related Macular Degeneration - Pipeline Review, H1 2014, provides an overview of the Age Related Macular Degenerations therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Age Related Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Age Related Macular Degeneration and special features on late-stage and discontinued projects.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=195129

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Table of Contents

Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Age Related Macular Degeneration Overview 11
Therapeutics Development 12
Pipeline Products for Age Related Macular Degeneration - Overview 12
Pipeline Products for Age Related Macular Degeneration - Comparative Analysis 13
Age Related Macular Degeneration - Therapeutics under Development by Companies 14
Age Related Macular Degeneration - Therapeutics under Investigation by Universities/Institutes 20
Age Related Macular Degeneration - Pipeline Products Glance 22
Late Stage Products 22
Clinical Stage Products 23
Early Stage Products 24
Unknown Stage Products 25
Age Related Macular Degeneration - Products under Development by Companies 26
Age Related Macular Degeneration - Products under Investigation by Universities/Institutes 30
Age Related Macular Degeneration - Companies Involved in Therapeutics Development 31
Alcon, Inc. 31
Genzyme Corporation 32
F. Hoffmann-La Roche Ltd. 33
Allergan, Inc. 34
Shionogi & Co., Ltd. 35
GlaxoSmithKline plc 36
Dainippon Sumitomo Pharma Co., Ltd. 37
RetinaPharma Technologies, Inc. 38

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Wednesday, 12 October 2016

Relapsed Multiple Myeloma - Pipeline Review, H1 2015: Key Venders such as 4SC AG, AB Science, AbbVie Inc., Arno Therapeutics, Acceleron Pharma

ResearchMoz added Latest Research Report titled " Relapsed Multiple Myeloma - Pipeline Review, H1 2015 " to it's Large Report database.

Global Markets Direct’s, ‘Relapsed Multiple Myeloma Pipeline Review, H1 2015’, provides an overview of the Relapsed Multiple Myeloma’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Relapsed Multiple Myeloma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Relapsed Multiple Myeloma and special features on late-stage and discontinued projects.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=279929

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Table of Contents

Table of Contents 2
List of Tables 6
List of Figures 8

Introduction 9
Global Markets Direct Report Coverage 9
Relapsed Multiple Myeloma Overview 10
Therapeutics Development 11
Pipeline Products for Relapsed Multiple Myeloma - Overview 11
Pipeline Products for Relapsed Multiple Myeloma - Comparative Analysis 12
Relapsed Multiple Myeloma - Therapeutics under Development by Companies 13
Relapsed Multiple Myeloma - Therapeutics under Investigation by Universities/Institutes 17
Relapsed Multiple Myeloma - Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Relapsed Multiple Myeloma - Products under Development by Companies 20
Relapsed Multiple Myeloma - Products under Investigation by Universities/Institutes 25
Relapsed Multiple Myeloma - Companies Involved in Therapeutics Development 26
4SC AG 26
AB Science 27
AbbVie Inc. 28
Acceleron Pharma, Inc. 29
Acetylon Pharmaceuticals, Inc. 30
Altor BioScience Corporation 31
Arno Therapeutics, Inc. 32

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Monday, 10 October 2016

Global Breast Cancer Market Report: 2015 Edition - Key Players Such as Hologic, Johnson and Johnson, Siemens AG, Roche and Novartis

ResearchMoz added Latest Research Report titled " Global Breast Cancer Market Report: 2015 Edition " to it's Large Report database.

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older.

In the past few years, the cases of breast cancer have increased tremendously in regions like the US and the Europe. The breast cancer market is driven by various factors like aging female population, obesity and diabetes, dense breast tissues, healthcare expenditure, exposure to X-Ray and Gamma Radiations, Estrogen-Progestin Therapy (EPT) and increased consumption of alcohol and tobacco. A major trend which will probably remain eternally in the breast cancer treatment industry is the fact that novel and innovative technologies and pharmaceutical molecules are always under development. Challenges associated with breast cancer are like, financial burdens associated with the treatment and adverse effects of Aromatase Inhibitors (AI) on patients.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=315089

The market for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative breast cancer drugs. Further, the companies are forming alliances and agreements to develop effective treatment methods for breast cancer.

The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, Brazil, Europe and APAC Countries. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include Hologic, Johnson and Johnson, Siemens AG, Roche and Novartis which are also profiled in this report.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Table of Content

1. Market Overview
1.1 Breast Cancer
1.2 Types of Breast Cancer
1.3 Risk Factors
1.4 Symptoms of Breast Cancer
1.5 Diagnosis and Treatment of Breast Cancer
1.5.1 Breast Cancer Screening and Diagnostic Measures
1.5.2 Breast Cancer Treatment

2. Breast Cancer Market
2.1 Global Market

    Diagnostics Market
    Therapeutic Market
    Market Segmentation

3. Regional Markets
3.1 The U.S. Breast Cancer Market
3.1.1 The U.S. Breast Cancer Diagnostics Market
3.1.2 The U.S. Breast Cancer Therapeutic Market
3.1.3 The U.S. Metastatic Breast Cancer Market
3.2. Brazilian Breast Cancer Market
3.2.1 Brazilian Breast Cancer Diagnostic Market
3.2.2 Brazilian Breast Cancer Therapeutic Market
3.3 APAC Countries
3.3.1 APAC Diagnostic Market
3.3.2 APAC Therapeutic Market

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG